STOP THE WAR! Let’s support Ukraine Together

Author: Nicholas Alan Clayton

IPO-Pricing
IPO-Pricing
Nuvve-logo

Newborn Acquisition Corp. (NBAC) Shareholders Approve Nuvve Deal

Newborn (NASDAQ:NBAC) announced that its shareholders have approved its combination with EV technology firm Nuvve at a special meeting held last evening. The parties now expect the deal to be completed in the next few days, after which the combined company’s shares and warrants will trade on the Nasdaq under the symbols “NVVE” and “NVVEW”,
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
IPO-Pricing
IPO-Pricing
IPO-Pricing
IPO-Pricing
purecycle-tech.2

FinTech Acquisition Corp. V (FTCV) to Combine with eToro in $9.6Bn Deal

FinTech V (NASDAQ:FTCV) has entered into a definitive agreement to combine with eToro at an enterprise value of $9.595 billion, or 9.7x its 2022E revenue. eToro is an online multi-asset investment platform with features like social investing and proprietary “smart portfolios.” The parties expect to complete the deal in the third quarter of 2021. Transaction
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
IPO-Pricing
IPO-Pricing
IPO-Pricing
IPO-Pricing
Fortress-Value-Acquisition-Corp-IV-logo
ironnet logo

LGL Systems Acquisition Corp. (DFNS) to Combine with IronNet in $927M Deal

LGL Systems (NYSE:DFNS) has entered into a definitive agreement to combine with IronNet Cybersecurity at an enterprise value of $926.7 million, or 17.1x its 2021E revenue. IronNet provides an advanced network detection and response (NDR) platform that identifies anomalous network activity during cyberattacks. The combined entity is expected to trade on the NYSE under the
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.

Therapeutics Acquisition Corp (RACA) to Combine with POINT Biopharma in $639M Deal

Therapeutics, doing-business-as Research Alliance Corp. I (NASDAQ:RACA), has entered into a definitive agreement to combine with POINT Biopharma at an enterprise value of $639.2 million. POINT is a clinical stage radiopharmaceutical firm researching the use of radioglands to treat cancer before and during chemotherapy. The combined entity is expected to trade on the Nasdaq under
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.

Cerberus Telecom Acquisition Corp. (CTAC) to Combine with KORE Wireless in $1Bn Deal

Cerberus Telecom (NYSE:CTAC) has entered into a definitive agreement to combine with internet-of-things (IoT) provider KORE Wireless at an enterprise value of $1.014 billion, or 4.9x its 2020 revenue. KORE provides connectivity hardware and service for smart devices and is working to move into the new world of 5G. The combined entity is expected to
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.
TOP-3
IPO-Pricing